TMEM194B Inhibitors

The chemical class of TMEM194B inhibitors comprises diverse compounds targeting specific pathways associated with TMEM194B regulation. Staurosporine, an ATP-competitive kinase inhibitor, directly targets the ATP-binding site of TMEM194B, disrupting its enzymatic activity. Wortmannin and LY294002 inhibit phosphoinositide 3-kinase (PI3K), disrupting the PI3K/Akt pathway involved in TMEM194B signaling. U0126 and PD98059 act as inhibitors of MEK, a kinase upstream of ERK1/2 in the MAPK pathway linked to TMEM194B activity.

SP600125 and SB203580 target JNK and p38 MAPK, respectively, modulating pathways that intersect with TMEM194B regulation. Rapamycin inhibits mTOR, influencing the mTOR pathway implicated in processes related to TMEM194B. PP2, a Src family kinase inhibitor, affects the Src kinase pathway associated with TMEM194B activity. SB431542 inhibits the TGF-β receptor, impacting the TGF-β signaling pathway that intersects with TMEM194B.

The chemical class of TMEM194B inhibitors thus encompasses compounds with varying specificities, each exerting its inhibitory effect on key signaling pathways connected to TMEM194B, ultimately regulating its biological functions.